NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 74 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $167,000 | +26.5% | 12,757 | +23.6% | 0.00% | – |
Q2 2022 | $132,000 | -48.6% | 10,325 | +14.8% | 0.00% | – |
Q1 2021 | $257,000 | -24.4% | 8,996 | -20.4% | 0.00% | – |
Q4 2020 | $340,000 | +37.1% | 11,302 | -26.4% | 0.00% | – |
Q3 2020 | $248,000 | +17.0% | 15,347 | +42.7% | 0.00% | – |
Q2 2020 | $212,000 | +57.0% | 10,756 | 0.0% | 0.00% | – |
Q1 2020 | $135,000 | -28.9% | 10,756 | +3.7% | 0.00% | – |
Q4 2019 | $190,000 | -47.7% | 10,371 | -60.5% | 0.00% | -100.0% |
Q3 2019 | $363,000 | – | 26,236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $232,513,000 | 49.48% |
Ponoi II Management, LLC | 1,298,908 | $16,652,000 | 45.25% |
Ponoi Management, LLC | 1,298,908 | $16,652,000 | 26.29% |
Euclidean Capital LLC | 746,674 | $9,572,000 | 8.14% |
StepStone Group LP | 1,573,357 | $20,170,000 | 2.16% |
First Light Asset Management, LLC | 1,135,884 | $14,562,000 | 1.69% |
Lexington Partners L.P. | 110,428 | $1,416,000 | 0.73% |
Rubric Capital Management LP | 797,588 | $10,225,000 | 0.54% |
Boxer Capital, LLC | 500,000 | $6,410,000 | 0.41% |
DAFNA Capital Management LLC | 107,653 | $1,380,000 | 0.38% |